Anti-WNT1 Antibody |产品详情|进口试剂采购网

您好，欢迎来到拜力生物网站！请登录注册

我的订单 | 联系我们 | 在线客服QQ：3012681483 | 客服电话：400-968-7988 | 工作时间：08:30-17:30

主营产品： ELISA试剂盒、抗体、补体血清、兔补体、干扰素、小鼠测温仪、进口试剂、Quidel代理、Swant代理、PBL Assay Science代理

网站首页产品中心代理品牌新闻资讯资源中心关于我们

所在位置：首页 > 产品中心 > Antibodies > Antibodies产品

订购信息

上海拜力生物科技公司

Tel:400-968-7988 021-33779008

Anti-WNT1 Antibody

品牌：Antibodies

货号：

规格：50µl

货期：

应用：

咨询客服

立即购买加入购物车

Anti-WNT1 Antibody

商品详情参考文献相关资料

Overview

Name:	Anti-WNT1 Antibody See all WNT1 primary antibodies
Description:	Rabbit polyclonal antibody to WNT1.
Applications:	WB
Dilutions:	WB: 1:1000 - 1:4000.
Reactivity:	Human, Mouse, Rat
Immunogen:	Recombinant protein of human WNT1.
Protein Length:	370
Host:	Rabbit
Clonality:	Polyclonal
Isotype:	IgG
Conjugate:	Unconjugated
Purification:	Affinity purification.
Product Form:	Liquid
Formulation:	Supplied in Phosphate Buffered Saline, pH 7.30, with 0.02% Sodium Azide and 50% Glycerol.
Storage:	Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Target

Function:	Ligand for members of the frizzled family of seven transmembrane receptors. In some developmental processes, is also a ligand for the coreceptor RYK, thus triggering Wnt signaling. Probable developmental protein. May be a signaling molecule important in CNS development. Is likely to signal over only few cell diameters. Has a role in osteoblast function and bone development.
Involvement in Disease:	Osteoporosis: A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs. Osteogenesis imperfecta 15: An autosomal recessive form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI15 is characterized by early-onset recurrent fractures, bone deformity, significant reduction of bone density, short stature, and, in some patients, blue sclerae. Tooth development and hearing are normal. Learning and developmental delays and brain anomalies have been observed in some patients.
Sequence Similarities:	Belongs to the Wnt family.
Post-Translational Modification:	Palmitoleylation is required for efficient binding to frizzled receptors. Palmitoleylation is necessary for proper trafficking to cell surface (Probable). Depalmitoleylated by NOTUM, leading to inhibit Wnt signaling pathway (By similarity).
Cellular Location:	Secreted > Extracellular space > Extracellular matrix.
Database Links:	Entrez Gene: 7471 Human Entrez Gene: 22408 Mouse Entrez Gene: 24881 Rat Omim: 164820 Human SwissProt: P04628 Human SwissProt: P04426 Mouse Unigene: 248164 Human Unigene: 1123 Mouse
Synonyms:	BMND16 Antibody INT1 Antibody OI15 Antibody oncogene Int1 Antibody Proto oncogene protein Wnt 1 Antibody Proto-oncogene Int-1 homolog Antibody Proto-oncogene Wnt-1 Antibody Wingless type MMTV integration site family member 1 Antibody wingless-type MMTV integration site family, member 1 (oncogene INT1) Antibody Wnt 1 Antibody Wnt1 Antibody WNT1_HUMAN Antibody
Information:	Target information shown above is from the UniProt Consortium.